Market Capitalization of Aurobindo Pharma (AUROPHARMA)
As of Sept. 18, 2026, Aurobindo Pharma (AUROPHARMA) market capitalisation is ₹96651.98 Cr ($10.74B), with 55.74 Cr shares outstanding at a current price of ₹1734.00 on NSE, ranking 116 out of 5367 companies by market cap in our screener. Aurobindo Pharma operates in the Healthcare sector and is classified as a Large Cap stock. Explore AUROPHARMA Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
Market Cap History of Aurobindo Pharma (Last 10 Years)
AUROPHARMA market capitalisation from year-end NSE closing prices over the last 10 years. View AUROPHARMA 52-week chart for the annual high/low range and current price position.
End of Year Market Cap History — Aurobindo Pharma
AUROPHARMA year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see AUROPHARMA share price.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹96651.98 Cr
$10.74B USD
|
₹1734.00 | NSE | +46.58% |
| 2025 |
₹65939.61 Cr
$7.33B USD
|
₹1183.00 | NSE | -11.35% |
| 2024 |
₹74384.12 Cr
$8.26B USD
|
₹1334.50 | NSE | +23.11% |
| 2023 |
₹60421.42 Cr
$6.71B USD
|
₹1084.00 | NSE | +147.32% |
| 2022 |
₹24430.54 Cr
$2.71B USD
|
₹438.30 | NSE | -40.31% |
| 2021 |
₹40932.17 Cr
$4.55B USD
|
₹734.35 | NSE | -20.29% |
| 2020 |
₹51352.64 Cr
$5.71B USD
|
₹921.30 | NSE | +101.66% |
| 2019 |
₹25464.51 Cr
$2.83B USD
|
₹456.85 | NSE | -37.67% |
| 2018 |
₹40854.13 Cr
$4.54B USD
|
₹732.95 | NSE | +6.54% |
| 2017 |
₹38345.86 Cr
$4.26B USD
|
₹687.95 | NSE | +2.79% |
| 2016 |
₹37306.33 Cr
$4.15B USD
|
₹669.30 | NSE | -23.59% |
| 2015 |
₹48824.86 Cr
$5.42B USD
|
₹875.95 | NSE | +54.26% |
| 2014 |
₹31651.57 Cr
$3.52B USD
|
₹567.85 | NSE | +189.13% |
| 2013 |
₹10947.20 Cr
$1.22B USD
|
₹196.40 | NSE | +107.39% |
| 2012 |
₹5278.51 Cr
$586.50M USD
|
₹94.70 | NSE | +122.40% |
| 2011 |
₹2373.38 Cr
$263.71M USD
|
₹42.58 | NSE | -67.59% |
| 2010 |
₹7323.59 Cr
$813.73M USD
|
₹131.39 | NSE | +44.08% |
| 2009 |
₹5082.87 Cr
$564.76M USD
|
₹91.19 | NSE | +441.51% |
| 2008 |
₹938.65 Cr
$104.29M USD
|
₹16.84 | NSE | -68.99% |
| 2007 |
₹3026.65 Cr
$336.29M USD
|
₹54.30 | NSE | -23.08% |
| 2006 |
₹3934.64 Cr
$437.18M USD
|
₹70.59 | NSE | +71.92% |
| 2005 |
₹2288.66 Cr
$254.30M USD
|
₹41.06 | NSE | +25.68% |
| 2004 |
₹1821.00 Cr
$202.33M USD
|
₹32.67 | NSE | -24.06% |
| 2003 |
₹2397.91 Cr
$266.43M USD
|
₹43.02 | NSE | - |